Table 5.
Adjusted difference scores between SMT and AET groups
Time of measurement | Outcome measures | ||
---|---|---|---|
VAS a (± 95% CI) | ODI b (± 95% CI) | SF-36 pain c (± 95% CI) | |
5-week Follow Up | |||
Negative on mCPR between | 7.16 (−20.32, 34.62) | 0.75 (−8.84, 10.23) | 0.21 (−1.99, 2.42) |
Positive on mCPR between | 0.81 (−31.21, 32.83) | 0.37 (−9.92, 10.66) | −0.03 (−2.84, 2.77) |
12-week Follow Up | |||
Negative on mCPR between | 5.36 (−68.25, 78.96) | 2.58 (−10.18, 15,34) | −0.66 (−2.30, 0.98) |
Positive on mCPR between | 2.48 (−11.32, 16.27) | 1.93 (−17.08, 20.94) | −0.50 (−2.48, 1.48) |
24-week Follow Up | |||
Negative on mCPR between | −4.26 (−34.82, 26,29) | 0.03 (−20.65, 20.70) | 0.16 (−1.85, 2.17) |
Positive on mCPR between | −8.50 (−48.75, 31.75) | −2.28 (−29.18, 24.62) | 0.11 (−2.05, 2.26) |
aA positive difference score indicates SMT group reported more pain in comparison to the AET group. A negative difference score indicates the AET group reported more pain in comparison to the SMT group. The larger the absolute value, the greater the difference.
bt A positive difference score indicates SMT group reported more disability in comparison to the AET group. A negative difference score indicates the AET group reported more disability in comparison to the SMT group. The larger the absolute value, the greater the difference.
cA positive difference score indicates SMT group reported less pain in comparison to the AET group. A negative difference score indicates the AET group reported less pain in comparison to the SMT group. The larger the absolute value, the greater the difference.